Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 30,000 shares at $55.27 ($1.6M) on 2024-07-23, disclosed to the SEC on 2024-07-24.
Scheduled sale ($1.6M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.46 | 4,709 | $256K | 15.6% |
| 2 | $54.46 | 4,709 | $256K | 15.6% |
| 3 | $55.27 | 5,291 | $292K | 17.7% |
| 4 | $55.27 | 5,291 | $292K | 17.7% |
| 5 | $55.12 | 10,000 | $551K | 33.4% |
| Total | $54.97 avg | 30,000 |
| $1.6M |
| 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-06-20 | $494K | — | Filing → |